Third Harmonic Bio (THRD) Earnings Date & Reports

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

THRD is expected to report earnings to fall 34.29% to -23 cents per share on August 07

Third Harmonic Bio THRD Stock Earnings Reports

Q2'25

Est.

$-0.23

Q1'25

Missed

by $0.09

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.01

The last earnings report on May 30 showed earnings per share of -34 cents, missing the estimate of -26 cents. With 183.33K shares outstanding, the current market capitalization sits at 238.05M.

View a ticker or compare two or three

Compare

THRD